Don't get left behind! The modernized ClinicalTrials.gov is coming. Check it out now.
Say goodbye to ClinicalTrials.gov!
The new site is coming soon - go to the modernized ClinicalTrials.gov
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of Cognitive Behavioral Therapy (CBT) for Child Anxiety Disorders in Community Clinics in Norway

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00735995
Recruitment Status : Completed
First Posted : August 15, 2008
Last Update Posted : September 26, 2018
Sponsor:
Collaborator:
The Research Council of Norway
Information provided by (Responsible Party):
Simon-Peter Neumer, Regionsenter for barn og unges psykiske helse

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The purpose of this study is to assess the effectiveness of a cognitive-behavioral intervention for children aged 7 to 12 years with anxiety disorders who are referred to ordinary community clinics. The treatment will be conducted as individual therapy or group therapy.

Condition or disease Intervention/treatment Phase
Separation Anxiety Disorder Social Phobia Generalized Anxiety Disorder Behavioral: Cognitive behavioral therapy (individual) Behavioral: Cognitive behavioral therapy (group) Phase 2

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 165 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effectiveness of Group and Individual Treatment of Childhood Anxiety Disorders in Community Clinics. A Randomized Controlled Trial.
Study Start Date : August 2008
Actual Primary Completion Date : October 2013
Actual Study Completion Date : December 2013

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Anxiety

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: A
Individual CBT
 Behavioral: Cognitive behavioral therapy (individual)
The Coping Cat program, 12 weekly sessions, two additional parent meetings
Experimental: B
Group CBT
 Behavioral: Cognitive behavioral therapy (group)
The Coping Cat program, 12 weekly sessions, two additional parent meetings
No Intervention: C
Waiting-list control


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Status of primary anxiety disorder at inclusion based on the ADIS interview schedule with parents and youth [ Time Frame: post-treatment and 2 year follow-up ]

Secondary Outcome Measures :
  1. Symptom score on the MASC [ Time Frame: post-treatment and 2 year follow-up ]
  2. CGAS [ Time Frame: post-treatment and 2 year follow-up ]

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   7 Years to 12 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Primary diagnosis of separation anxiety disorder, social phobia or generalized anxiety disorder based on the ADIS interview schedule, DSM-IV criteria

Exclusion Criteria:

  • Pervasive Developmental Disorder
  • Psychotic symptoms
  • Intelligence score < 70
  • Use of medications with anxiety reducing effects during treatment
  • Neither parent competent in Norwegian language
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00735995


Locations
Layout table for location information
Norway
Akershus Universitetssykehus HF
Lorenskog, Norway, 1478
Sykehuset Asker og Baerum, Baerum BUP
Rud, Norway, 1309
Sykehus Telemark Helseforetak, Skien og Porsgrunn BUP
Skien, Norway
Sponsors and Collaborators
Regionsenter for barn og unges psykiske helse
The Research Council of Norway
Investigators
Layout table for investigator information
Principal Investigator: Simon-Peter Neumer, dr.philos Regionsenter for barn og unges psykiske helse
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications of Results:
Villabø MA, Gere MK, Torgersen S, Arnberg K, Neumer SP, Kendall PC. Anxious self-statements in clinic-referred US and Norwegian anxiety-disordered youth. Cognitive Therapy and Research 37(4): 840-850, 2013.

Layout table for additonal information
Responsible Party: Simon-Peter Neumer, dr. Simon-Peter Neumer, Regionsenter for barn og unges psykiske helse
ClinicalTrials.gov Identifier: NCT00735995    
Other Study ID Numbers: 186036/V50
186036 ( Other Grant/Funding Number: Norwegian Research Council )
First Posted: August 15, 2008    Key Record Dates
Last Update Posted: September 26, 2018
Last Verified: September 2018
Additional relevant MeSH terms:
Layout table for MeSH terms
Disease
Anxiety Disorders
Phobia, Social
Anxiety, Separation
 Pathologic Processes
Mental Disorders
Phobic Disorders
Neurodevelopmental Disorders